A Randomized, Multicenter, Open-Label, Phase III Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab (IMB-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First Line Treatment of Patients with Stage IV Squamous Non-Small Cell Lung

Grants and Contracts Details

StatusFinished
Effective start/end date2/11/11 → 1/31/13

Funding

  • PPD Development Inc: $4,250.00